John Wijdenes

John Wijdenes publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where John Wijdenes sits on this spectrum.

John Wijdenes D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where John Wijdenes sits on this spectrum.

Best Publications

• Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production.

  T. C. T. M. Van Der Pouw Kraan;L. C. M. Boeije;R. J. T. Smeenk;J. Wijdenes

  1000
  Citations

• Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus.

  Luis Llorente;Weiping Zou;Yves Levy;Yvonne Richaud-Patin

  686
  Citations

• Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus

  Luis Llorente;Yvonne Richaud-Patin;Carlos García-Padilla;Emmanuel Claret

  590
  Citations

• Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody.

  Joseph T. Beck;Su-Ming Hsu;John Wijdenes;Regis Bataille

  563
  Citations

• Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia.

  B Klein;J Wijdenes;XG Zhang;M Jourdan

  527
  Citations

• In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity.

  Luis Llorente;Yvonne Richaud‐Patin;Renato Fior;Jorge Alcocer‐Varela

  472
  Citations

• Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice.

  Eric Tartour;François Fossiez;Isabelle Joyeux;Annie Galinha

  444
  Citations

• A plasmocyte selective monoclonal antibody (B-B4) recognizes syndecan-1.

  John Wijdenes;Wim C. Vooijs;Claude Clément;Jacob Post

  443
  Citations

• Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function.

  Jan Kubach;Petra Lutter;Tobias Bopp;Sabine Stoll

  279
  Citations

• Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody.

  Unknown

  279
  Citations

• Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus.

  L Llorente;Y Richaud-Patin;J Wijdenes;J Alcocer-Varela

  276
  Citations

• Soluble IL-6 Receptor Potentiates the Antagonistic Activity of Soluble gp130 on IL-6 Responses

  Gerhard Müller-Newen;Andrea Küster;Ulrike Hemmann;Radovan Keul

  236
  Citations

• Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect on lymphoma growth and on B clinical symptoms.

  D Emilie;J Wijdenes;C Gisselbrecht;B Jarrousse

  236
  Citations

• Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes.

  Unknown

  232
  Citations

• Phase I-II trial of a monoclonal anti-tumor necrosis factor alpha antibody for the treatment of refractory severe acute graft-versus-host disease.

  P Herve;M Flesch;P Tiberghien;J Wijdenes

  227
  Citations

• Production and characterization of a monoclonal antibody specific for the human lymphocyte low affinity receptor for IgE: CD 23 is a low affinity receptor for IgE.

  J Y Bonnefoy;J P Aubry;C Peronne;J Wijdenes

  216
  Citations

• Treatment of corticosteroid resistant acute graft-versus-host disease by in vivo administration of anti-interleukin-2 receptor monoclonal antibody (B-B10)

  P Herve;J Wijdenes;JP Bergerat;P Bordigoni

  209
  Citations

• Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis.

  Pierre Miossec;Jérǒme Briolay;Julie Dechanet;John Wijdenes

  197
  Citations

• Cytotoxic activity of the maytansinoid immunoconjugate B-B4-DM1 against CD138+ multiple myeloma cells.

  Pierfrancesco Tassone;Victor S. Goldmacher;Paola Neri;Antonella Gozzini

  188
  Citations

• The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells

  Michel Jourdan;Martine Ferlin;Eric Legouffe;Mira Horvathova

  187
  Citations